Trifluoroacetic acid → 5-(5-(3-Hydroxy-3-methylbut-1-ynyl)-4-(piperidin-4-ylmethylamino)pyridin-2-ylamino)pyrazine-2-carbonitrile

HRID 384711

반응식

HRID 384711 반응식
C(O)(C(F)(F)F)=O.[C:8]([C:10]1[N:11]=[CH:12][C:13]([NH:16][C:17]2[CH:22]=[C:21]([NH:23][CH2:24][CH:25]3[CH2:30][CH2:29][N:28](C(OC(C)(C)C)=O)[CH2:27][CH2:26]3)[C:20]([C:38]#[C:39][C:40]([OH:43])([CH3:42])[CH3:41])=[CH:19][N:18]=2)=[N:14][CH:15]=1)#[N:9]>ClCCl>[OH:43][C:40]([CH3:42])([CH3:41])[C:39]#[C:38][C:20]1[C:21]([NH:23][CH2:24][CH:25]2[CH2:26][CH2:27][NH:28][CH2:29][CH2:30]2)=[CH:22][C:17]([NH:16][C:13]2[N:14]=[CH:15][C:10]([C:8]#[N:9])=[N:11][CH:12]=2)=[N:18][CH:19]=1

참가 물질

4

실험 절차

TFA (0.2 mL) was added at room temperature to a solution of tert-butyl 4-((2-(5-cyanopyrazin-2-ylamino)-5-(3-hydroxy-3-methylbut-1-ynyl)pyridin-4-ylamino)methyl)piperidine-1-carboxylate (0.020 g, 0.041 mmol) dissolved in dichloromethane (2 mL). The reaction mixture was stirred for 20 min. Solvent was removed in vacuo and the crude mixture was purified by ion exchange on SCX-II acidic resin (500 mg), eluting with methanol then 2M ammonia-methanol. The basic fractions were combined and solvent was removed in vacuo. The crude product was purified by preparative thin layer chromatography, eluting with methanol/dichloromethane (1/19), to give the title compound as a yellow solid (0.008 g, 50%).

후처리

  1. customSolvent was removed in vacuo
  2. customthe crude mixture was purified by ion exchange on SCX-II acidic resin (500 mg)
  3. washeluting with methanol
  4. customsolvent was removed in vacuo
  5. customThe crude product was purified by preparative thin layer chromatography
  6. washeluting with methanol/dichloromethane (1/19)

출처 및 근거

ORD 기록
ord-3fd9a182b05f4c0ebd28ac1143b6ec18
출처 데이터셋
uspto-grants-2013_02
특허 번호
US08367658B2

연결된 노트

불러오는 중…